Top Medical Groups Issue Clear Vaccine Guidance Amid Political Turmoil

When the federal government’s vaccine messaging started to sound more like a carousel than a road map, a coalition of professional societies decided to step in and hand the public a straight‑forward guide. The American Academy of Pediatrics, the American Academy of Family Physicians, the American College of Obstetricians and Gynecologists and the Infectious Diseases Society of America put their heads together and published a set of recommendations that actually reflect the science, not the politics.

Why now? Since early 2025 the Trump administration has been chipping away at long‑standing vaccine advice—first by pulling the universal COVID‑19 recommendation, then by issuing a January 2026 memo that stripped away routine childhood shots for flu, meningococcal disease, COVID‑19 and hepatitis A and B. The move sparked lawsuits, and a federal judge in March blocked the parts concerning COVID‑19 and Hep B. Even with the court’s stay, the administration pressed on, with an executive order that touted “more vaccine flexibility” while echoing unfounded claims about safety.

Enter the Vaccine Integrity Project at the University of Minnesota. Working side‑by‑side with the American Medical Association, the group sifted through close to 300 peer‑reviewed studies, looking for solid, reproducible evidence. Their findings were published in JAMA, and the resulting guidance was framed around three core ideas: transparency, relevance to individual risk, and a clear, jargon‑free presentation for patients.

Flu shots, still the workhorse. The new consensus mirrors the CDC’s long‑standing advice: everyone six months old and up—yes, even pregnant people—should get a flu vaccine each season, unless a specific medical condition says otherwise. For folks 65 and older, the recommendation leans toward a high‑dose formulation—think Fluzone High‑Dose, Flublok recombinant, or Fluad adjuvanted. Data from the Vaccine Integrity Project show that, in seniors, flu vaccination cuts hospitalizations by roughly 31 %. Children and teens see about an 80 % drop in flu‑related deaths when the virus is confirmed in the lab, and babies whose mothers were vaccinated during pregnancy enjoy a 44 % lower risk of symptomatic illness in the first six months of life.

There’s also a newcomer: an mRNA‑based flu vaccine approved by the FDA in August 2026 for people over 50. One study suggested it was about 27 % more effective than the traditional shot in older adults—a modest but welcome boost.

COVID‑19, now a shared decision. After the CDC removed the blanket recommendation for healthy children and pregnant adults in May 2025, the conversation shifted. The agency now urges “shared clinical decision‑making” for anyone six months and older. In plain English: you and your doctor weigh the pros and cons together, rather than following a one‑size‑fits‑all rule.

The societies’ practical take is an annual COVID‑19 vaccine for most people, with a few nuances. All children aged 6‑23 months should receive it each year. Kids 2‑18 years get a dose if they belong to a risk group or simply want it. Adults 19‑64—including pregnant people—should consider an annual shot, while those 65 and older are advised to get a dose now and another six months later.

Lastly, the guidance touches on RSV, a virus that has re‑emerged as a serious cause of pediatric hospitalizations. The recommendation mirrors the flu approach: vaccinate all infants 6 months and older and consider maternal vaccination during pregnancy to protect newborns.

“The American public deserves clear, credible information,” said AMA President‑elect Dr. Sandra Adamson Fryhofer in a press release. By grounding their advice in a systematic review and presenting it in everyday language, these groups hope to cut through the noise and let people make informed choices about the shots that matter most.